---
schema_version: "secwatch.filing_event.v1"
accession: "0001854270-24-000094"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2024-07-17T23:59:59+00:00"
generated_at: "2026-05-31T20:16:43.822295+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences effectuates 1-for-10 reverse stock split effective July 17, 2024

## Summary
- Reverse stock split at 1-for-10 ratio approved by Board on July 10, 2024.
- Effective 5:00 p.m. ET on July 17, 2024; trading on split-adjusted basis begins July 18 under symbol SNTI.
- No fractional shares issued; cash payment in lieu at July 17 closing price.
- Authorized shares and par value remain unchanged; new CUSIP is 81726A209.
- Reverse split intended to maintain Nasdaq listing compliance; proportional adjustments to equity awards.

## SEC filing metadata
- accession: 0001854270-24-000094
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2024-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/0001854270-24-000094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/snti-20240717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001854270-24-000094
- JSON: https://secwatch.observer/filing/0001854270-24-000094.json
- Plain text: https://secwatch.observer/filing/0001854270-24-000094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.